PopulationsHumans11,052 participants90 daysCohort study

Prior GLP-1RA or Tirzepatide Use and Early Cardiorenal Outcomes After Metabolic and Bariatric Surgery

Figure 1 from The American Journal of Medicine — Figure 1Tseng et al.

The American Journal of Medicine

The paper

Tseng TC, Chang R

The American Journal of Medicine · 14 Sep 2026

doi.org/10.1016/j.amjmed.2026.09.010 PubMed 42735883

GLP-1 receptor agonists link to lower stroke and Alzheimer risk
Neurology Genetics · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026